Recent Articles

January 22, 2015 11:50 am
Mike Auerbach, Editor In Chief
Particle Sciences, a drug development services company located in Bethlehem, Pennsylvania, has based its business model on being platform/technology agnostic. Bring them your drug development, formulation or dosage form problem and they will apply the right set of tools and technology to advance your project.
January 15, 2015 1:50 pm
Andrew Szal, Editor, Pharmaceutical Processing
As biologic drugs like Humira and Enbrel become a larger and larger part of the pharmaceutical market, a new report from attorneys at Goodwin Procter says the introduction of lower-cost generic versions called “biosimilars” may be close at hand. 
Subscribe to Pharmaceutical Processing